Company Profile

Company Description

Protalix BioTherapeutics is a biopharmaceutical company focused on the development and commercialization of recombinant therapeutic proteins using its proprietary plant cell-based expression system. The company specializes in treatments for rare and genetic disorders, including enzyme replacement therapies. Its innovative technology platform offers cost-effective and scalable production of complex biologics, addressing unmet medical needs. Protalix collaborates with global partners to expand access to its therapies while maintaining a strong pipeline of novel drug candidates. The company is known for its commitment to advancing science and improving patient outcomes through cutting-edge biotechnological solutions.